J P Phair
Overview
Explore the profile of J P Phair including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
209
Citations
4297
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Seaberg E, Witt M, Jacobson L, Detels R, Rinaldo C, Young S, et al.
J Viral Hepat
. 2014 Oct;
21(10):696-705.
PMID: 25280229
We examined the characteristics associated with hepatitis C virus (HCV) antibody (anti-HCV) prevalence and HCV clearance between injection drug using (IDU) and non-IDU men who have sex with men (MSM)....
2.
Taiwo B, Li X, Palella F, Jacobson L, Margolick J, Detels R, et al.
HIV Med
. 2009 Jul;
10(10):657-60.
PMID: 19601997
Background: The clinical implications of a failure to achieve high CD4 cell counts while receiving virally suppressive highly active antiretroviral therapy (HAART) are uncertain. Methods: We analysed data from HIV-infected...
3.
Gange S, Mellors J, Lau B, Detels R, Phair J, Munoz A, et al.
AIDS Res Hum Retroviruses
. 2001 Sep;
17(13):1223-9.
PMID: 11559421
Longitudinal measurements of plasma HIV RNA were analyzed using novel segmented regression models for 62 men in the Multicenter AIDS Cohort Study who at enrollment in 1985 were HIV seropositive...
4.
Tarwater P, Margolick J, Jin J, Phair J, Detels R, Rinaldo C, et al.
J Acquir Immune Defic Syndr
. 2001 Jun;
27(2):168-75.
PMID: 11404539
We evaluated CD4 cell counts over a 3(1/2) year period following the initiation of potent antiretroviral therapy (ART) in the Multicenter AIDS Cohort Study. The study population included 314 HIV-infected...
5.
Yamashita T, Phair J, Munoz A, Margolick J, Detels R, OBrien S, et al.
AIDS
. 2001 May;
15(6):735-46.
PMID: 11371688
Objectives: To evaluate prior antiretroviral therapy experience and host characteristics as determinants of immunologic and virologic response to highly active antiretroviral therapy (HAART). Methods: We studied 397 men from the...
6.
7.
Detels R, Tarwater P, Phair J, Margolick J, Riddler S, Munoz A
AIDS
. 2001 Mar;
15(3):347-55.
PMID: 11273215
Objectives: To determine the effectiveness of potent antiretroviral therapy in reducing opportunistic infections (OI) as both a presenting event and subsequent to an AIDS-defining event. Design And Methods: A total...
8.
Kleeberger C, Phair J, Strathdee S, Detels R, Kingsley L, Jacobson L
J Acquir Immune Defic Syndr
. 2001 Feb;
26(1):82-92.
PMID: 11176272
Assessment of adherence to HIV antiretroviral therapy (ART) is required for studying therapeutic effectiveness and identifying subgroups needing focused education. The study's goals were to describe the level of ART...
9.
Jacobson L, Gore M, Strathdee S, Phair J, Riddler S, Detels R
J Clin Epidemiol
. 2001 Feb;
54(2):149-56.
PMID: 11166530
Antiretroviral therapy (ART) use was examined in a cohort of homosexual men infected with HIV-1 for long periods. Multivariate logistic regression models, stratified by clinical indication (below and above 500...
10.
Lyles R, Munoz A, Yamashita T, Bazmi H, Detels R, Rinaldo C, et al.
J Infect Dis
. 2000 Mar;
181(3):872-80.
PMID: 10720507
The natural history of human immunodeficiency virus type 1 (HIV-1) viremia and its association with clinical outcomes after seroconversion was characterized in a cohort of homosexual men. HIV-1 RNA was...